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A B S T R A C T
Consumption of traditional fermented dairy products (tFDP) in Africa leads to the ingestion of up to 108
Streptococcus infantarius subspecies infantarius (Sii) per millilitre of spontaneously fermented milk. Sii is a
member of the Streptococcus bovis/Streptococcus equinus complex (SBSEC) for which some members are asso-
ciated particularly with colorectal cancer or endocarditis. The extent of health risks to tFDP consumers is largely
unknown.
A hospital-based unmatched case-control study was conducted at Kenyatta National Hospital, Nairobi (Kenya)
on 80 cases and 193 controls that were selected exhaustively from patients attending colonoscopy at the hos-
pital. Logistic regression models adjusted for age, sex and residency were used in the statistical analysis.
Consumption of tFDP was not associated with CRC (odds ratio (OR) 1.4; 95% Conﬁdence interval (CI) 0.7–2.7;
p = 0.34). Risk factors associated with CRC included age above 40 years, and consumption of processed meat
and alcohol. Faecal carriage of Sii was signiﬁcantly higher in persons with colon tumours and polyps compared
to controls (8.4% vs 21.6%: OR: 4.6; CI 1.3–15.9). Patients with haemorrhoids represented an unexpected carrier
group with signiﬁcantly higher Sii faecal carriage (30.4%, CI: 17.7–45.8). Consumption of tFDP does not re-
present risk factors for CRC whereas Sii seems to be associated with CRC. However, there is urgent need to assess
this ﬁnding also in the general population, investigate the causality of SBSEC, Sii and CRC as well as compare the
phylogenetic, functional and genomic relationship between human and dairy Sii with regards to the ongoing
application of Sii in FDP production.
1. Introduction
Globally, colorectal cancer (CRC) is the third most common cancer
among men and second among women (International Agency for
Research on Cancer, 2012) with nearly 1.4 million new cases diagnosed
in 2012 (World Cancer Research Fund, 2016). In Kenya, CRC ranks 7th
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for cancers in both sexes with a cumulative incidence of 4.2 per
100,000 persons per year (International Agency for Research on
Cancer, 2012; Korir et al., 2015). CRC is associated with a number of
environmental factors including: age above 50 years, smoking, drinking
alcohol, obesity, consumption of saturated fats and red meat (Joint
WHO/FAO expert consultation group, 2003). Microorganisms such as
members of the Streptococcus bovis/Streptococcus equinus complex
(SBSEC) have also been associated with CRC (Ben-Chetrit et al., 2017;
Boleij and Tjalsma, 2013; Corredoira et al., 2015). Despite this asso-
ciation, some SBSEC members are also given commensal status in the
gastrointestinal tract of humans and animals, while recent studies have
even shown that traditional fermented dairy products (tFDP) in Africa
are predominated by Streptococcus infantarius subsp. infantarius (Sii) and
to a lesser extent by Streptococcus gallolyticus subsp. macedonicus (Sgm)
(Jans et al., 2013b) with up to 108 live Sii per millilitre of tFDP
(Abdelgadir et al., 2008; Jans et al., 2012a). Sii and Sgm are members of
the SBSEC (Jans et al., 2015; Schlegel et al., 2003). The SBSEC and CRC
correlation was originally associated to S. bovis (Klein et al., 1977).
Advancing taxonomic diﬀerentiation speciﬁed this association mainly
to Streptococcus gallolyticus subsp. gallolyticus (Sgg) formerly classiﬁed as
S. bovis biotype I and Streptococcus gallolyticus subsp. pasteurianus (Sgp),
formerly biotype II.2 (Ben-Chetrit et al., 2017; Jans et al., 2015).
However, these advances in taxonomic diﬀerentiation among the
SBSEC opened questions on disease associations of the S. infantarius
branch (biotype II.1) including Sii and Streptococcus lutetiensis (inter-
mediately named Streptococcus infantarius subsp. coli). Disease associa-
tion with infective endocarditis and other clinical syndromes was par-
tially clariﬁed for S. lutetiensis but not for Sii as accurate
epidemiological data on Sii is scarce (Ben-Chetrit et al., 2017; Jans
et al., 2015; Romero et al., 2011). In parallel to taxonomic advances,
some Sii strains have been reclassiﬁed as Streptococcus equinus while
others implicated as human or livestock pathogens were conﬁrmed to
be Sii suggesting the need to investigate the role of Sii with respect to
public health (Jans et al., 2016). This is particularly important for the
sub Saharan African setting where exposure of humans to live Sii
through food such as tFDP is high in multiple countries (Abdelgadir
et al., 2008; Jans et al., 2012a, 2016, 2013b; Wullschleger et al., 2013).
The long tradition and wide distribution of tFDPs as food products
in sub-Saharan Africa reﬂects the important role of tFDP in nutrition,
food safety and food security for communities in this region (Franz
et al., 2014; Jans et al., 2017). Considering the large population con-
suming and relying on tFDP as part of their diet, the elucidation of the
role of Sii is pivotal. Comparative genomics and phylogenetic analyses
of Sii strains indicated two main African Sii lineages with a rather recent
and currently ongoing process of dairy adaptation (Jans et al., 2016,
2013a, 2012b). The dairy adaptations of Sii lineages seem to parallel
the evolution of Streptococcus thermophilus as starter culture in Western
fermented dairy products and suggest an important technological role
during tFDP manufacturing (Jans et al., 2013a). In this context, African
variants of Sii have been suggested for evaluation as indigenous starter
culture for African tFDP (Jans et al., 2016, 2013a). Therefore, a thor-
ough safety assessment of Sii for any future product development and
estimation of its public health risk is necessary. However, basic ap-
propriate epidemiological data on Sii in Africa and even worldwide is
currently lacking.
To provide the ﬁrst epidemiologic data on CRC, tFDP and Sii, we
implemented a hospital-based study and enrolled patients at the en-
doscopy unit of Kenyatta National Hospital (KNH) in Nairobi, Kenya, a
country with well-characterized Sii-containing tFDP. The main objec-
tives of this study were: i) assessing the relationship between the con-
sumption of tFDP and colon-related health conditions, ii) determining
the prevalence of Sii in patients with diﬀerent colon-related health
conditions, and iii) identifying additional environmental risk factors
such as consumption of other food products, smoking, drinking alcohol,
obesity and level of physical activity.
2. Materials and methods
2.1. Study design
2.1.1. Sample size determination of participants and dairy diet
The anticipated sample size of individuals involved as study subjects
was determined assuming a proportion exposed to the consumption of
tFDP of 60% (Jans et al., 2013b) among controls and 75% among cases
and a case/control ratio of 1:3. Applying Fleiss’ formula for unmatched
case control studies, 104 cases and 310 controls are required to detect a
statistically signiﬁcant diﬀerence with a power of 80% at the 95% level
of conﬁdence. Concerning the dairy diet, it was distinguished between
(1) traditional FDP (tFDP) from spontaneously fermented raw milk in-
cluding informal sour milk (tFDP1) and home-made sour milk (tFDP2);
(2) sour milk from heat-treated milk and subsequently fermented with
commercial non-Sii-starter cultures (cFDP), often named mala/lala; (3)
Western-type yoghurt with light/medium to ﬁrm consistency made
from heat-treated milk by commercial starter cultures containing S.
thermophilus (yFDP); and (4) cereal-based porridge with either type
cFDP or tFDP before cooking the porridge.
2.1.2. Case deﬁnition, inclusion and exclusion criteria
Participants were stratiﬁed by the outcome of the colonoscopy to
either patients with normal colon (including minor complications such
as constipation, abdominal pains or helminths), CRC, adenocarcinoma
(polyps), colitis, haemorrhoids or other. A case was deﬁned as an in-
dividual whose diagnosis showed colon tumours or polyps while con-
trols were deﬁned as individuals with normal colon. To increase sta-
tistical power and to prove that the results are not sensitive to the case
deﬁnition, two alternative deﬁnitions were considered by including
patients with colitis, haemorrhoids or other conditions once in the case
and once in the control group (Fig. 1). The inclusion criteria were
persons of 18 years and above referred for colonoscopy examination.
Participants matching the following exclusion criteria were not con-
sidered for the study: undertaking chemotherapy, radiotherapy or sur-
gery and pregnancy. Age was self-reported by participants or derived
from their date of birth where available.
2.1.3. Participant enrolment and interview
All adult individuals attending KNH for colon examination by co-
lonoscopy at the Endoscopy unit were invited to participate. They were
briefed on the study goals and risks, according to the ethical guidelines
including the signing of a consent form for voluntary study participa-
tion. This was then followed by interviewer-guided ﬁlling of the ques-
tionnaire, a process that took approximately 30 min. Questionnaires
were administered in English, Swahili or local dialect with the help of a
translator if needed.
Fig. 1. Data ﬂow diagram of participant recruitment among endoscopy patients at
Kenyatta National Hospital, stratiﬁcation by endoscopy examination outcome and case
deﬁnition (CD) to determine colorectal cancer (CRC), Sii/SBSEC and FDP association.
Alternative case deﬁnitions (Alt.CD) were formulated for sensitivity analysis.
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2.1.4. Clinical specimen collection
The colonoscopy revealed the colon health status while micro-
biological analysis on the clinical samples allowed for detection and
isolation of Sii and SBSEC. All clinical specimens were collected by a
registered nurse or doctor (gastroenterologist) of KNH. Blood sample
(4.5 mL) and a rectal swab were obtained before colonoscopy. Blood
sample collection followed the international standards (World Health
Organization, 2010). The collection of rectal swabs was performed by
the medical staﬀ before standard colonoscopy procedure was per-
formed. A sterile swab was used after the anal area was cleaned with
70% ethanol to reduce exterior microorganisms. The swab was inserted
into the rectum, rotated gently and removed. The swab was then re-
placed into the sterile holder until streaking on the culture media the
same day. Faecal sample collection was planned in such a way not to
interfere with the routine colonoscopy preparation procedures of KNH.
Faecal sample collection was therefore performed at home level by the
participant prior to self-administration of laxatives the day before co-
lonoscopy. The sterile single-use stool collection tube was issued during
the initial participant recruitment. CRC or polyp or tissue samples were
collected and screened for SBSEC bacteria when such a tissue sample
was taken by the physician for CRC screening. Initial microbiological
analyses of all samples were performed at the same day by the in-house
bacteriology laboratory of KNH. Histology examination of suspected
cancerous tissue samples from the colon of patients was diﬀerentiated
as follows: malignant lesions/carcinoma were summarized under the
term “tumour”. Histology did however not diﬀerentiate between neo-
plastic and non-neoplastic polyp types. The class “polyps” therefore
summarizes both types. According to the initially formulated case de-
ﬁnition, patients with tumours or polyps were considered as cases.
2.1.5. Ethical considerations and approvals for the study
This study was approved in Kenya by the Kenyatta National
Hospital/University of Nairobi Ethics and Research Committee ap-
proval number P389/07/2012. In Switzerland, Ethics Committees of
ETH Zurich and Kantonale Ethik Kommission Zurich approved the
study under decision numbers EK 2013-N-78 and KEK-StV-Nr. 47/14,
respectively. The study participants gave consent during enrolment to
the study. The study was conducted in accordance with the Declaration
of Helsinki (World Medical Association, 2013).
2.2. Data collection tools and variables
A structured questionnaire was designed to capture various vari-
ables including demographic and socio-economic status, colonic dis-
orders, co-morbidities, physical activity, familial history of CRC, height,
weight and food consumption. A check list for clinical samples that
included rectal swab, faeces, blood and tumour/polyp tissue was in-
cluded.
2.3. Microbiological analysis of human clinical samples and isolation of
presumptive SBSEC strains
2.3.1. Reference strains
Reference strains were obtained from the culture collections of the
Laboratory of Food Biotechnology of ETH Zurich (LFBT, Zurich,
Switzerland), Culture Collection of the University of Gothenburg
(CCUG, Gothenburg, Sweden) and the Deutsche Stammsammlung für
Mikroorganismen und Zellkulturen GmbH (DSMZ, Braunschweig,
Germany). All analyses were performed using Sii CJ18 (Jans et al.,
2012b), Sii CCUG43820T, Sgg DSM16831T, Streptococcus thermophilus
DSM20259, and Enterococcus faecium DSM20477T as reference strains.
2.3.2. Growth media, supplements and chemical reagents
KF Streptococcus (KFS, Becton Dickinson, Allschwil, Switzerland),
Mitis Salivarius (MS, Becton Dickinson), Brain Heart Infusion (BHI,
Biolife, Milan, Italy) and Trypton Soy Broth (Sigma-Aldrich, Buchs,
Switzerland) including corresponding supplements were prepared ac-
cording to manufacturers’ instructions. All chemicals were obtained
from Sigma-Aldrich (Buchs, Switzerland) unless noted otherwise.
2.3.3. Microbiologic analysis of human clinical samples
The blood sample was transferred into universal biphasic glass
culture bottles (Biomerieux, France) containing sterile Tryptone Soy
Broth (Sigma-Aldrich) by injecting through the rubber stopper. Blood
cultures were incubated at 37 °C without agitation. Visual examination
of blood cultures was performed within 24 h and at daily intervals
thereafter for 5–7 days. Visual evidence of microbial growth included
turbidity, haemolysis, gas production or formed colonies in the un-
disturbed sedimented blood.
Rectal swabs were streaked on KFS (Becton Dickinson) and MS
(Becton Dickinson) agar media by rubbing the swab on the agar surface.
The swab was then dipped in saline solution and streaked onto a 2nd
agar medium of both agar types as a secondary cultivation mean. Stool
samples were serially diluted to 10−3. Subsequently, approximately
15 μL of each stool sample dilution as well as the pure stool sample
were streaked onto KFS and MS agar media using a sterile inoculation
loop. KFS and MS agar media were incubated at 37 °C for 24–48 h
under aerobic conditions to isolate facultative anaerobe Sii/SBSEC and
suppress strict anaerobe members of the gut microbiota.
2.3.4. Macro-morphological characterization and isolation of presumptive
SBSEC members
After incubation, qualitative description of colonies on KFS and MS
agar media was performed by describing their size, colour, edge and
surface texture. Two colonies of each morphology type were isolated
per medium per participant and streak-puriﬁed on the corresponding
medium. Each isolate was thereby traceable back to its origin. Puriﬁed
stock cultures were then stored in BHI broth containing 33% (v/v)
glycerol.
2.3.5. Identiﬁcation of presumptive SBSEC members by molecular tools
DNA of puriﬁed strains was extracted and subsequently used in rep-
PCR ﬁngerprinting, SBSEC-speciﬁc 16S rRNA gene PCR-assay and
partial groEL ampliﬁcation and sequencing as previously described
(Jans et al., 2016, 2013b, 2012c). All primers for these three PCR assays
and sequencing were obtained from Microsynth (Balgach, Switzerland).
PCR Master Mix 2 × concentrated (Thermo Scientiﬁc, St. Leon-Rot,
Germany) was used for all assays. Sanger sequencing of puriﬁed DNA
amplicons was performed at GATC using the individual primers from
the corresponding PCR assay (Konstanz, Germany).
2.3.6. Identiﬁcation of non-SBSEC isolates by 16S rRNA gene sequencing
To elucidate the species status of bacterial isolates not identiﬁed as
SBSEC members, a universal 16S rRNA gene PCR assay using bak4 and
bak11 w primers was performed (Amann et al., 1990; Greisen et al.,
1994). For that, 30 isolates originating from 25 participants re-
presenting 30 diﬀerent rep ﬁngerprints were selected among the overall
non-SBSEC isolate pool consisting in 1356 isolates. Ampliﬁed DNA
fragments of the 16S rRNA gene were then sequenced at Microsynth
(Switzerland) using bak11 w as Sanger sequencing primer.
2.4. Statistical data analysis
The database was created in Microsoft Access (Microsoft
Corporation, Redmond, WA, USA) and statistical data analysis con-
ducted using Stata version 14 (Stata Corporation, College Station, TX,
USA, 1984–2000). Dietary intake variables assessed by a semi-quanti-
tative food frequency questionnaire were analysed by using logistic
regression adjusted for age group (< 40, 41–60 and>60yrs), gender
and rural residency. Odds ratios (OR) with their corresponding 95%
conﬁdence intervals (CI) were used to measure strength of associations
with P-values of less than 0.05 considered statistically signiﬁcant. All
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DNA sequence analyses were performed in CLC Genomics Workbench
(version 7.5, Qiagen Aarhus A/S, Denmark). Raw sequence chromato-
grams were trimmed for quality using a minimum stringency setting of
0.01. Trimmed sequences were then queried against the GenBank da-
tabase using NCBI Blast algorithm to obtain the most likely species
identiﬁcation.
3. Results
In total, 449 participants were enrolled in the study out of which 34
did not complete colonoscopy and an additional two were excluded
because of age below 18 to arrive a sample size of 413 participants
(Fig. 1). To allow for designing the case and control groups, the parti-
cipants were classiﬁed depending on their colon health status, resulting
in 193 (46.7%) normal colon, 16 (3.8%) colon with tumour (carci-
noma), 64 (15.5%) polyps (non-neoplastic and neoplastic/adenoma),
84 (20.8%) haemorrhoids, 43 (10.4%) colitis and 13 (3.1%) other
conditions. Therefore, this study is based on case deﬁnition one (Fig. 1)
that includes colon with tumour (carcinoma) or polyps (non-neoplastic
and neoplastic/adenoma) as the case group (80 participants) while the
control group includes participants with normal colon (193 partici-
pants), to yield the study population of 273 for the case-control study.
However, clinical samples were available from 196 participants.
3.1. Demographic characteristics of the study population
The mean age among cases was 54 years (standard deviation, sd 16)
compared to 46 years (sd 14) among controls. In the control group, 51%
of the participants were male compared to 59% in the case group
(Table 1). About 65% of the cases had an educational level above pri-
mary school but only 49% of the controls. For about half of the patients
the reason for referral was available. The most common reason was
rectal bleeding (36% cases, 30% controls) followed by chronic con-
stipation (13% cases, 30% controls). First and second degree of familial
history of colorectal cancer was not assessed for association with CRC/
polyps, due to low numbers.
Higher potential risk towards CRC was associated with living in
rural areas than urban areas (unadjusted OR 1.6; 95%CI 1.0–2.7;
P = 0.08) (Table 1). Human ownership or contact with livestock and
several socio-economic indicators were associated with a higher risk of
CRC but none were statistically signiﬁcant.
Forty six percent of the cases had normal BMI but 27.0% were pre-
obese (Table 1). Self-reported chronic health conditions were mainly
stomach ulcers (26.3% cases: 22.8% controls) and high blood pressure
(25.0% cases; 20.7% controls). The most recent co-morbidities or
symptoms of infections were stomach pain (51.3% cases; controls
40.9%), fatigue (48.8% cases; 48.2% controls) and constipation (41.2%
cases; 34.7% controls).
3.2. Association between fermented (FDP) and non-fermented dairy
products and adenocarcinoma
In general, the consumption of tFDP was associated with slightly
elevated but not statistically signiﬁcant risks of CRC (OR 1.4; CI
0.7–2.7; P = 0.34) (Table 2). Starter culture made commercial sour
milk (cFDP) (mala/lala) was not associated with an increased risk (OR
1.0; CI 0.6–1.7; P = 0.95) while yoghurt (yFDP) consumption showed a
slightly but not signiﬁcant decreased risk CRC (OR 0.8; CI 0.4–1.4;
P = 0.47).
Consumption of cereal-based porridge containing cFDP or yFDP was
not associated with an increased risk (OR 0.6; CI 0.2–1.8; P = 0.36).
Adding plain milk to tea or coﬀee showed slightly elevated risks for
CRC (OR 2.1; CI 1.0-4.8; P = 0.06) whereas tea without milk (OR 0.7;
CI 0.3–1.4; P = 0.28) and coﬀee without milk (OR 1.2; CI 0.6–2.6;
P = 0.61) did not. The values did not change noteworthy when other
case deﬁnitions were applied (Fig. A.1 in the Supplementary material).
We assume that the load of viable SBSEC reaching the intestinal tract
can be neglected in all the consumed products except for tFDP, since
raw milk, the assumed vector of SBSEC, did undergo at least one heat
treatment step during the production process or the preparation process
at home level.
3.3. Association of consumption of other foods with CRC
All sausages types were associated with increased risk of CRC; pork
sausages (OR 2.5; CI 1.2–5.1; P = 0.01), chicken sausages (OR 2.6; CI
0.9–8.0; P = 0.09) and beef sausages (OR 1.9; CI 1.1–3.4; P = 0.03)
(Table A.1 in the Supplementary material). In addition, poultry (OR
1.9), processed sandwich meat (OR 2.1), roasted red beef (OR 1.7) and
unroasted red meet (OR 1.3) were associated with CRC, however, not
reaching signiﬁcance levels. All other food products such as bacon, ﬁsh
and canned beef, beans, lentils, green grams and peas showed no no-
teworthy association.
3.4. Association of lifestyle characteristics with CRC
Alcohol consumption for a period of more than nine years was not
associated to CRC likely due to low number of corresponding study
participants (controls 13/193; cases 8/80) (Table A.2 in the
Supplementary material). However, alcohol consumption showed an
increased risk for CRC, which was statistically signiﬁcant higher in
participants that reported former alcohol consumption (OR 2.2; CI
1.2–4.0; P = 0.02) or ever consumed alcohol (OR 2.2; CI 1.2–4.2;
P = 0.01). Similarly, smoking showed slightly increased risks of CRC
but this association was not statistically signiﬁcant even for participants
who have smoked for more than seven years. There was no evidence
that physical activities were associated with CRC (Table A.2 in the
Supplementary material).
3.5. Prevalence of Sii/SBSEC and co-isolated non-SBSEC bacteria among
clinical samples and participants
From the overall 413 participants only 196 provided clinical sam-
ples comprised of 196 rectal swabs samples, 163 blood samples, 23
faecal and 4 polyp biopsy samples. Clinical sample types were obtained
only once per participant. None of the four polyp biopsy samples
yielded presumptive Sii/SBSEC isolates while no bacterial colonies were
observed from the 163 blood samples. From the rectal swabs and faecal
samples, 1386 presumptive SBSEC isolates were obtained. Of these,
1053 and 333 were obtained from MS Agar and KFS Agar, respectively.
DNA of all 1386 rectal swab and faecal isolates was ampliﬁed using a
rep-PCR assay. Clustering by sample and rep-ﬁngerprint to obtain one
representative isolate per ﬁngerprint per sample yielded 812 unique
isolate DNA samples out of the total of 1386 isolates for further pro-
cessing by the SBSEC-speciﬁc PCR assay. Fifty-nine out of the 812 were
conﬁrmed SBSEC isolates. Using the rep-ﬁngerprint clustering to re-
calculate overall prevalence, 95 out of 1386 (6.9%) isolates were as-
signed to the SBSEC. For subspecies identiﬁcation, partial sequencing of
the groEL gene was performed to identify the 95 isolates identiﬁed as
SBSEC members. Via rep-ﬁngerprint linkage, groEL sequencing yielded
72 Sii, 6 S. lutetiensis, 1 Sgm, 12 Sgp and 4 untyped SBSEC members. Sgg
and S. equinus were not isolated. The 95 SBSEC isolates were obtained
from 46 out of 196 participants that provided clinical samples. This
resulted in an overall SBSEC patient prevalence of 23.5%. Out of these
patients, 31 were determined positive only for Sii, 7 only for Sgp, 2 only
for S. lutetiensis and 1 for a not further identiﬁed SBSEC isolate.
Combined carriage of SBSEC species was detected in 1 patient each for
Sii& Sgm, Sii& Sgp and S. lutetiensis& Sgp. Two patients were de-
termined to carry Sii& S. lutetiensis.
A limited selection of isolates (n = 30 out of 1356) from highly
prevalent rep-PCR ﬁngerprints of isolates not identiﬁed as SBSEC
member were subjected to partial 16S rRNA gene sequencing. The
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Table 1
Socio-economic, demographic symptomatology traits in association with CRC of the study population.
N = 273 Normal GIT CRC OR 95% CI P-value
n = 193 % n = 80 %
Age
18 to 30 28 14.5 9 11.3 1.4a 1.2–1.5 0.001
31 to 40 42 21.8 6 7.5
41 to 50 45 23.3 15 18.8
51 to 60 44 22.8 16 20.0
61 to 70 18 9.3 19 23.8
over 70 16 8.3 15 18.8
age over50 78 40.4 50 62.5 2.5 1.4–4.2 0.001
Gender
Male 100 51.8 47 58.8 –
Female 93 48.2 33 41.3 0.8 0.4–1.3 0.30
Education
Did not go to school 10 5.2 9 11.4 –
Primary 58 30.2 31 39.2 0.6 0.2–1.6 0.31
Secondary 73 38.0 23 29.1 0.4 0.1–1.0 0.04
Tertiary 43 22.4 9 11.4 0.2 0.1–0.7 0.01
University 8 4.2 7 8.9 1.0 0.3–3.8 0.97
Household size
One 16 8.3 5 6.3 –
2–4 including children 59 30.6 19 23.8 1.0 0.3–3.2 1.0
4–6 including children 34 17.6 12 15.0 1.1 0.3–3.8 0.8
> 6 including children 17 8.8 12 15.0 2.3 0.6–7.9 0.2
Marital status
Single 48 24.9 14 17.5 –
Married 139 72.0 61 76.3 1.5 0.7–2.9 0.23
Separated 6 3.1 4 5.0 2.3 0.6–9.2 0.25
Familial history for CRC
1st degree relatives 7 3.6 2 2.5 ndb
2nd degree relatives 7 3.6 3 3.7 nd
Residence
Urban residence 107 55.4 35 43.8 –b
Rural residence 86 44.6 45 56.3 1.6 1.0–2.7 0.08
Own livestock
No 71 36.8 21 26.3 –
Yes 52 26.9 26 32.5 1.7 0.9–3.3 0.13
Contact with livestock
No 178 92.2 70 87.5 –
Yes 15 7.8 10 12.5 1.9 0.8–4.6 0.15
Occupation
Dependent 45 23.3 21 26.3 –
Employed 62 32.1 20 25.0 0.7 0.3–1.4 0.32
Business person 46 23.8 14 17.5 0.7 0.3–1.4 0.29
Self-employed 21 10.9 12 15.0 1.2 0.5–2.9 0.65
Casual labourer 16 8.3 13 16.3 1.7 0.7–4.3 0.23
Roof Material
Iron sheets 134 69.4 57 70.0 –
Rooﬁng tiles 11 5.7 11 13.8 2.3 1.0–5.8 0.06
Grass thatched 1 0.5 1 1.3 2.4 0.1–38.9 0.54
Concrete 44 22.8 11 13.8 0.6 0.3–1.2 0.17
Source of drinking water
Tap water 139 72.0 55 68.8 –
Borehole water 31 16.1 12 15.0 1.0 0.5–2.0 0.95
Rain water/pondc 23 11.9 13 16.3 1.4 0.7–3.0 0.35
BMI
Underweight 15 7.8 8 10.0 0.9a 0.7–1.0 0.15
Normal BMI 73 37.8 37 46.3
Preobesity 54 28.0 22 27.5
Obesity grade I 28 14.5 6 7.5
Obesity grade II/III 23 11.9 7 8.8
Self-reported chronic health conditions nd
Heart problems 8 4.2 5 6.3
High blood pressure 40 20.7 20 25.0
Lung problem 9 4.7 6 7.5
Stomach ulcers 44 22.8 21 26.3
Diabetes 11 5.7 7 8.8
Liver problem 9 4.7 3 3.8
Pneumonia 16 8.3 4 5.0
Any cancer 6 3.1 1 1.3
Arthritis 19 9.8 7 8.8
Recent weight loss 28 14.5 15 18.8
Recurring boils 9 4.7 2 2.5
Self-reported health conditions (5 days preceding the interview) nd
(continued on next page)
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isolates originated from 25 out of 196 participants. Half of the 30
strains were identiﬁed as Enterococcus faecalis, four Streptococcus sali-
varius and two Enterococcus durans. Out of the remaining nine isolates,
ﬁve could not be identiﬁed while single isolates of Cyanobacteria spp,
Lactococcus lactis, Leuconostoc lactis and Streptococcus agalactiae were
described.
3.6. Prevalence of Sii stratiﬁed by colon health condition and association of
faecal carriage by consumption of dairy products
The prevalence of Sii was 17.3% (34 out of 196 participants). The
observed prevalence of Sii was signiﬁcantly lower in the control group
(8.4%, vs 21.6%: OR: 4.6; CI 1.3–15.9) indicating that Sii is associated
with CRC. Interestingly, the highest prevalence of 30.4% (n: 46; CI:
17.7%-45.8%) was observed in participants diagnosed with haemor-
rhoids (Fig. 2). Similarly, prevalence of SBSEC carriage was lower
among controls compared to cases (13.7 vs 21.6%; OR: 2.1; CI: 0.7–6.3)
but the association was not statistically signiﬁcant. Again SBSEC pre-
valence was highest for haemorrhoids 39.1% (18/46).
Among the 196 persons that contributed a clinical sample, the
persons who consumed tFDP (14.3%; n = 49) featured a lower Sii
carriage prevalence compared to the non-consumers (14.3% vs. 18.4%;
OR: 0.7; CI 0.3–1.8). Consumers of yoghurt (yFDP) had Sii detected less
often (13.6%; n = 103) than participants that did not consume yFDP
(21.5%; n = 93). cFDP consumers had a carriage rate of 11.5% (10/87)
in contrast to 22.0% (24/109) among non-consumers of cFDP. Separate
calculations for exclusive tFDP consumers without yFDP or cFPD con-
sumption were not performed due to a sample number of only 8 pa-
tients that would not yield meaningful conclusions.
4. Discussion
The determination of exposure and outcome information as well as
control of confounders represent important steps in establishing a
Table 1 (continued)
N = 273 Normal GIT CRC OR 95% CI P-value
n = 193 % n = 80 %
Chills 27 14.0 13 16.3
Fever w/no chills 29 15.0 16 20.0
Fatigue 93 48.2 39 48.8
Flu-like illness 48 24.9 13 16.3
Loss of appetite 53 27.5 27 33.8
Coughing 51 26.4 18 22.5
Back pain 61 31.6 27 33.8
Stomach pain 79 40.9 41 51.3
Vomiting 27 14.0 13 16.3
Constipation 67 34.7 33 41.2
Painful joints 60 31.1 26 32.5
OR: odds ratio, not adjusted.
a OR per unit change in ordered categories – presented is the linear eﬀect determined by Orthogonal Polynomial Coding.
b not determined.
c rainwater/pond: rain water run oﬀ collected in water pans, lagoons or sand dams.
Table 2
Food consumption in relation to CRC among cases and controls in the study population.
N = 273 Controls Cases ORA 95% CI P-value
n = 193 % n= 80 %
Raw cow milk 5 2.6 3 3.8 1.5 0.3–6.9 0.62
Pasteurized cow
milk
105 54.4 48 60.0 1.3 0.8–2.3 0.33
Pasteurized goat
milk
4 2.1 4 5.0 2.5 0.6–11.6 0.23
Spontaneously FDP
(tFDP)
36 18.7 19 23.8 1.4 0.7–2.7 0.34
tFDP1 6 3.1 4 5.0 1.9 0.5–7.6 0.33
tFDP2 20 10.3 9 11.3 1.1 0.5–2.7 0.78
Both tFDP1 and
tFDP2
10 5.1 6 7.5 1.5 0.5–4.7 0.42
Starter culture sour
milk (mala/lala)
(cFDP)
77 39.9 31 38.8 1.0 0.6–1.7 0.95
Yoghurt intake
(yFDP)
93 48.2 29 36.3 0.8 0.5–1.4 0.47
Yoghurt sweeteneda 46 23.8 16 20.0 0.8 0.4–1.7 0.63
Yoghurt with fruit 28 14.5 4 5.0 0.4 0.1–1.4 0.17
Yoghurt natural 7 3.6 3 3.8 1.0 0.2–4.2 0.98
yFDP type
combinations
12 6.2 4 7.5 1.2 0.4–3.4 0.76
Butter 4 2.1 3 3.8 2.1 0.4–10.6 0.34
Tea with milk 153 79.3 71 88.8 2.1 1.0–4.8 0.06
Tea w/no milk 45 23.3 15 18.8 0.7 0.3–1.4 0.28
Coﬀee with milk 39 20.2 21 26.3 1.8 1.0–3.5 0.07
Coﬀee w/no milk 30 15.5 12 15.0 1.2 0.6–2.6 0.61
Porridge WFMb 16 8.3 5 6.3 0.6 0.2–1.8 0.36
Porridge WNMc 51 26.4 25 31.3 1.1 0.6–2.0 0.81
ORA: adjusted odds ratio.
a Yoghurt with added sweeteners and ﬂavours.
b WMF: porridge with fermented milk. Fermented milk was added into the porridge
during preparation.
c WNM: porridge without fermented milk. Raw milk was added into the porridge
during preparation.
Fig. 2. Faecal carriage of SBSEC (dark grey) and Sii (light grey) in persons with CRC and
those with normal colon, haemorrhoids, colitis and other conditions. Error bars indicate
95% conﬁdence interval (CI) boundaries.
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suspected epidemiological link between potential risk factors and
cancer (Susser, 1973). tFDP in several sub-Saharan countries contain
high levels of live Sii (Abdelgadir et al., 2008; Jans et al., 2012a, 2013b;
Wullschleger et al., 2013). Recently, a 9.4% isolate prevalence of Sii
was also reported in artisanal cheese from North Eastern Brazil
(Medeiros et al., 2016) as well as tFDP in Bangladesh (Jans et al., 2016;
Rashid et al., 2007) indicating the relevance of the ﬁndings of this study
beyond Africa (Jans et al., 2015). The association of faecal carriage of
Sii and consumption of tFDP and CRC had not been previously reported
in the literature. Therefore, our study elucidated the link between ex-
posures such as consumption of tFDP and other food groups, Sii faecal
carriage, smoking, drinking of alcohol, engaging in physical activity as
well as contact with livestock and the presence of CRC.
In this study, the proportion of males to females in the control
group, was inversely proportional to the community level of Kenya’s
national distribution (51% females; 49% males) (Kenya National
Bureau of Statistics, 2010). However, the case group had a signiﬁcant
higher number of males than women, which can be expected for CRC
(International Agency for Research on Cancer, 2012). This study also
conﬁrmed that the association of age above 50 years was a risk factor to
CRC (Howlader et al., 2015), even though the age group of 40–49 years
was also at risk of CRC. Thereby, the logistic regression models were
adjusted for age, gender and rural residence.
In this study, Sii was elevated among persons with CRC when
compared to persons with normal colon (21.6%:8.4%) showed similar
associations for Sii to CRC as to those of other SBSEC members (Ben-
Chetrit et al., 2017). The implied health risk of this Sii carriage in re-
lation to CRC will require further investigations to elucidate causality of
SBSEC and Sii in CRC as well as functional and genomic comparisons
between the diﬀerent Sii lineages. So far, little evidence on Sii-related
diseases is available as mostly S. lutetiensis was detected or if S. in-
fantarius-speciﬁc disease associations were reported then without dif-
ferentiation between Sii and S. lutetiensis (Ben-Chetrit et al., 2017;
Corredoira et al., 2013). Previous studies implicating SBSEC or S. in-
fantarius in human infections might therefore require additional follow
up work to elucidate the epidemiologic and functional data under the
more discriminative current SBSEC taxonomy (Ben-Chetrit et al., 2017;
Jans et al., 2016, 2015). Furthermore, larger study settings in hospitals
and among the general population will be needed for enhanced insights
into the epidemiology and disease associations of the SBSEC subspecies.
To estimate the public health risk posed by Sii, it remains to be
investigated whether Sii possesses proliferative advantage during co-
lonic malignancies as reported for Sgg (Tjalsma et al., 2012). The pre-
valence of colonic malignancy in this study was higher (29.3%; 80 out
of 273) than 18.9% previously reported from a similar study setup in
France (Chirouze et al., 2013). This could in part be related to diﬀerent
hospital populations and particularly low health care insurance cov-
erage in Kenya (Kazungu and Barasa, 2017). This low coverage could
lead people to only seek care when a disease is already progressed far
and would thus yield a more pronounced stage of malignancy devel-
opment. However, colon malignancy among both hospital populations
was still signiﬁcantly lower than that determined for IE patients of up to
69% (Olmos et al., 2016) and 84.6% (Alozie et al., 2015).
The prevalence reported for Sii in this study was similar to 11% Sii
prevalence determined for rectal swabs of colonoscopy patients in
Brazil using a qPCR assay (Lopes et al., 2014). In contrast, general
SBSEC prevalence in France was reported at 6% for normal colonoscopy
(Chirouze et al., 2013). In Taiwan, Sgp was predominant at 47–58%
among a colorectal screening population using a blood-agar and API-
based typing approach, while S. infantarius branch members (S. lute-
tiensis and Sii) were the second most predominant SBSEC group at
36–42% (Huang et al., 2008). Sequencing-based comparison of the gut
microbiota composition of Ghanaian and Dutch infants also revealed
diﬀerent relative abundances of SBSEC members by geography and
vaccination response (Harris et al., 2017). Thus, overall SBSEC and
SBSEC species prevalence seems to diﬀer by geography as previously
reported for gut microbiota composition (Yatsunenko et al., 2012).
Furthermore, isolation and identiﬁcation methodology as well as dif-
ferences in study population composition among these hospital-based
studies might contribute to the observed diﬀerences. Particularly for
this study, the possible consumption of Sii via tFDP should not be ne-
glected.
This study is the ﬁrst assessment of Sii in relation to food con-
sumption, human diseases and carriage. In the presented study, we
found no evidence that FDP consumption increases the risk of CRC. It
seems that products such as yoghurt (yFDP) and cultured sour milk
(mala/lala) (cFDP), originating from industrial processes, likely with
‘good manufacturing practices’ concepts implemented, had inverse or
slight inverse association with CRC or faecal carriage of Sii. Out of these
FDP, only tFDP is expected to contain Sii but not yFDP or cFDP (Jans
et al., 2017). It remains to be investigated whether the obtained human
Sii in this study are related to the dairy adapted African variants present
in sub-Saharan Africa or rather represent commensal lineages (Jans
et al., 2016). However, the presence of Sii also in non-tFDP consumers
suggests at least a secondary source from the environment, animals or
simply indicates commensal status of certain Sii in the gastrointestinal
tract of humans.
Foods that were signiﬁcantly associated with CRC in our study, were
eggs, pork sausages and beef salami. While the association of processed
red meat products with increased risk of CRC has been established
(Santarelli et al., 2008), the case for eggs is less clear. Previous studies
have suggested the association of CRC with high cholesterol and pos-
sibly egg consumption (Jarvinen et al., 2001; Lee et al., 2009; Steinmetz
and Potter, 1994), evidence is however still incomplete and will require
further research.
Other foods with potential risk towards CRC were chicken sausages,
poultry with skin, processed meat, pork and roast beef. Multiple studies
associated consumption of red meat with an increased risk of colorectal
adenomas and cancers (Joint WHO/FAO expert consultation group,
2003 Murdoch et al., 2009). However, it is still unclear whether this
eﬀect was attributable to substances in red meat or changes resulting
during cooking and processing (Joint WHO/FAO expert consultation
group, 2003).
This study identiﬁed alcohol consumption as a major risk factor of
developing CRC. Consumption of alcohol, cigarette smoking (Erhardt
et al., 2002; IARC Working Group on the Evaluation of Carcinogenic
Risks to Humans, 1988; Jedrychowski et al., 2002; Pﬂaum et al., 2016)
and lack of adequate levels of physical activity have been previously
reported to be associated with CRC (International Agency for Research
on Cancer and world health organization, 2002; World Health
Organization, 2002). CRC association with alcohol intake is con-
centrated mainly on persons that had low folate intake (Joint WHO/
FAO expert consultation group, 2003). Also drinking small amounts of
alcohol may not increase the risk of developing CRC (World Health
Organization, 2002). However, other studies indicated that smoking
and alcohol use leads to increased oxidative stress that subsequently
leads to DNA damage and consequently lead to CRC (Valko et al.,
2004).
This study did not reveal a single blood isolate of Sii or other SBSEC
members from the collected blood samples. Participants were not hos-
pitalized for infective endocarditis or bacteraemia. In contrast, many
other studies that examined participants by colonoscopy primarily re-
cruited among bacteraemia and infective endocarditis patients. Among
these endocarditis patients, SBSEC members were identiﬁed from only
6% of all positive blood cultures assays (Alozie et al., 2015; Chirouze
et al., 2013; Corredoira et al., 2015; Olmos et al., 2016). Therefore, the
absence of SBSEC members from blood cultures of participants enrolled
in this study meets the expectations.
The Mitis Salivarius agar used in this study allowed for a semi-se-
lective isolation of Sii as the main study objective. Preliminary tests
using SBSEC type strains of Sii, S. lutetiensis, Sgg, Sgp, Sgm, S. equinus, S.
bovis and S. alactolyticus as well as over 30 Sii and S. lutetiensis strains
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from human and tFDP sources allowed cultivation of all strains except
S. alactolyticus DSM 20728T under the applied conditions on MS agar
(data not shown). Therefore, the probability of false negative outcomes
is expected to be minimal for Sii, S. lutetiensis, Sgm, Sgg, Sgp and S. bovis/
S. equinus.
5. Limitations
This study had the following limitations: the study was designed as a
case-control study based at the health-facility and therefore recruited
participants may not represent the overall population of the country or
a certain geographic location of the country. The participant selection
was potentially skewed towards certain colonic health conditions.
The study relied on histology examination of colon tissue samples
for diagnosis of cancer state. Histology examination returned the status
for tumour (carcinoma) and polyp. However, colorectal polyps were not
diﬀerentiated further between non-neoplastic and neoplastic types.
Non-neoplastic polyps have no malignant potential, which includes
benign lesions (hyperplastic polyps). Neoplastic polyps include pre-
malignant (adenoma) or malignant (carcinoma) types of which the later
was determined by histologists as tumour (carcinoma). Available pa-
tient data from KNH do not allow separating the study population into
non-neoplastic and neoplastic polyp types. Therefore, a mixed health
status concerning non-neoplastic (benign) and neoplastic (adenoma)
polyp types was obtained for all participants classiﬁed as polyp carriers
in this study. Alternative case deﬁnitions were deﬁned to perform
corresponding sensitivity analyses.
The usual intake of various foods including FDP was assessed by
food frequency questionnaires. Thereby, data on quantiﬁcation of
portion sizes or daily intakes was limiting. However, such ques-
tionnaires were successfully employed by others suggesting their ap-
plicability to the settings in this study (Haftenberger et al., 2010;
Tantamango et al., 2011).
6. Conclusions
Our study indicated no increase in risk towards CRC through tFDP
consumption but an association of Sii with CRC. Interestingly, con-
sumption of tFDP and other FDPs lead to a slight decrease in faecal
carriage of Sii. Unexpectedly, this study also revealed an elevated faecal
carriage of Sii in persons with haemorrhoids, which requires further
investigations. In addition, the rural population is at greater risk to-
wards CRC than urban dwellers. This might not be explained within the
scope of this study, even though there is higher proportion of the over-
50-year-old persons living in the rural regions.
The presence of Sii in many tFDP consuming and non-consuming
participants without CRC or colon disorders suggests a potential com-
mensalism of Sii in humans. However, due to the CRC association, the
novel ﬁnding of haemorrhoid association and still unknown patho-
genicity factors potentially shared between Sii and other SBSEC mem-
bers, further genetic and functional characterization of the diﬀerent
strains and phylogenetic Sii lineages as well as epidemiologic data will
be required to formulate appropriate and sustainable interventions.
These interventions will target the millions of tFDP consumers in sub-
Saharan Africa and in other regions of the world where Sii is present in
tFDP and will therefore need to be based on strong scientiﬁc evidence.
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